On April 25, AbbVie (NYSE: ABBV ) (NEOE: ABBV:CA ) released financial results for the first three months of 2025, which not only once again beat the expectations of Wall Street analysts but, more importantly, under the leadership of Rob Michael, itsWith over two decades of dedicated experience in investment, Allka Research has been a guiding force for individuals seeking lucrative opportunities. Its conservative approach sets it apart, consistently unearthing undervalued assets within the realms of ETFs, co ...